Erasca
ERAS
141 hedge funds and large institutions have $469M invested in Erasca in 2025 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 43 reducing their positions, and 16 closing their positions.
735% more call options, than puts
Call options by funds: $618K | Put options by funds: $74K
69% more capital invested
Capital invested by funds: $277M → $469M (+$191M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
1% less funds holding
Funds holding: 142 → 141 (-1)
5% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 43
1.23% less ownership
Funds ownership: 76.99% → 75.76% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$4M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$2.63M |
| 3 |
Goldman Sachs
New York
|
+$1.11M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$544K |
| 5 |
Renaissance Technologies
New York
|
+$433K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$2.46M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.91M |
| 3 |
Millennium Management
New York
|
-$1.4M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.36M |
| 5 |
JG
Jain Global
New York
|
-$983K |
ERAS Hedge Fund Activity: Q3 2025 in Review
141 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q3 2025, worth a combined $469M — up 69% from $277M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ERAS positions and 16 closed out — a net gain of 1 holder — while 41 added to existing stakes and 43 trimmed.
The largest buyer was Vivo Capital, adding an estimated $4M. The largest seller was Marshall Wace, cutting an estimated $2.46M.
- 141 institutional investors held Erasca (ERAS) as of Q3 2025, down from 142 in Q2 2025.
- Funds reported $469M of Erasca stock for Q3 2025, up 69% quarter-over-quarter.
- 17 funds opened new Erasca positions in Q3 2025 and 16 closed out, a net change of +1 holder.
- The largest Erasca buyer in Q3 2025 was Vivo Capital, an estimated $4M added.
- The largest Erasca seller in Q3 2025 was Marshall Wace, an estimated $2.46M sold.
Based on aggregated 13F filings for Q3 2025.